0
Skip to Content
kathy skantzos
about
services
portfolio
contact
kathy skantzos
about
services
portfolio
contact
about
services
portfolio
contact
Breathing easy: new ways to manage asthma
Medical Forum Magazine Kathy Skantzos 17/12/22 Medical Forum Magazine Kathy Skantzos 17/12/22

Breathing easy: new ways to manage asthma

Navigating newer treatments and medications for asthma are key to helping the millions of Australians living with the sometimes-fatal condition breathe easier.

Read More
Silverchain commemorates 40 years of palliative care
Medical Forum Magazine Kathy Skantzos 1/11/22 Medical Forum Magazine Kathy Skantzos 1/11/22

Silverchain commemorates 40 years of palliative care

Many Australians wish to die at home rather than in hospital and one organisation has made that possible for the past 40 years.

Read More
Reaching out to cancer patients and families
Medical Forum Magazine Kathy Skantzos 3/5/22 Medical Forum Magazine Kathy Skantzos 3/5/22

Reaching out to cancer patients and families

With one in seven women affected by breast cancer in their lifetime, there is new focus on the psychological impact of the disease, as Kathy Skantzos explains.

Read More
COVID-19 and the heart of the matter
Medical Forum Magazine Kathy Skantzos 12/4/22 Medical Forum Magazine Kathy Skantzos 12/4/22

COVID-19 and the heart of the matter

As the COVID pandemic continues to run its course, research is showing the wider implications of the disease.

Read More
Medicinal cannabis gains traction
Medical Forum Magazine Kathy Skantzos 2/3/22 Medical Forum Magazine Kathy Skantzos 2/3/22

Medicinal cannabis gains traction

Not only are more doctors prescribing medicinal cannabis to patients, it is turning into big business.

Read More
Paving the path to better Alzheimer’s treatments
Medical Forum Magazine Kathy Skantzos 8/11/21 Medical Forum Magazine Kathy Skantzos 8/11/21

Paving the path to better Alzheimer’s treatments

The first drug to target the underlying cause of Alzheimer’s disease rather than merely addressing its symptoms could be available in Australia as early as next year if approved by the Therapeutic Goods Administration.

Read More

about services portfolio contact

kathy skantzos